![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](dn6032contents.gif)
Acta Cryst. (2002). E58, o723-o725 [ doi:10.1107/S1600536802009492 ]
Abstract: The title compound, C16H19BrN2O2S, is an intermediate in the set of reactions leading to 2-bromoethylnitrososulfamides, a new family of promising therapeutic compounds. The molecules are linked by an N-H
O hydrogen-bond interaction.
Online 8 juin 2002
Copyright © International Union of Crystallography
IUCr Webmaster